How Do We Treat?
Hematology and Oncology have seen rapid progress and advances during recent years. Increased knowledge of tumor biology, epidemiology, molecular genetics, growth regulation,
and cellular functions has led to novel therapeutic paradigms. Targeted treatment approaches, antibodies, immunotherapy, and other new techniques complement classic chemotherapy, radiotherapy, and surgery. In this dynamic and fast-paced environment, it is of central importance to base clinical decisions and medical practice on the best available evidence. Continuous quality management, with clinical process documentation, standardization, and evaluation, leads to improved patient care and long-term outcomes. For these reasons, we have started to systematically capture and evaluate data on diagnosis, treatment, and outcomes of patients with solid tumors and hematological neoplasms at the Freiburg University Medical Center. We have developed standard operating procedures, clinical pathways, and diagnostic and therapeutic processes, following the principles of “Good Clinical Practice.”
